Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis

by William Hinton, Michael D. Feher, Neil Munro, Mark Joy, Simon de Lusignan
Published 2021-06-01

Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease

by Anthony S. Wierzbicki, Phillip D. Mayne, Matthew D. Lloyd, David Burston, Guam Mei, Margaret C. Sidey, Michael D. Feher, F. Brian Gibberd
Published 2003-08-01

Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional studyResearch in context

by Anna K. Forbes, William Hinton, Michael D. Feher, William Elson, Mark Joy, José M. Ordóñez-Mena, Xuejuan Fan, Nicholas I. Cole, Debasish Banerjee, Rebecca J. Suckling, Simon de Lusignan, Pauline A. Swift
Published 2024-02-01